Taiwan Association for the Study of Small Intestinal Diseases(TASSID)

Latest News

Articles

Articles - Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects

Scand J Gastroenterol. 2015 Nov 23:1-10. [Epub ahead of print]

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.

Chung CS1,2,3, Chang PF4,5, Liao CH6, Lee TH1, Chen Y7, Lee YC8, Wu MS8, Wang HP8, Ni YH9.


Author information

1a Department of Internal Medicine , Far Eastern Memorial Hospital , New Taipei City , Taiwan ;
2b College of Medicine , Fu Jen Catholic University , New Taipei City , Taiwan ;
3c Taiwan Association for the Study of Small Intestinal Diseases (TASSID) , New Taipei City , Taiwan ;
4d Department of Pediatrics , Far Eastern Memorial Hospital , New Taipei City , Taiwan ;
5e Department of Healthcare Administration , Oriental Institute of Technology , New Taipei City , Taiwan ;
6f Department of Infectious Diseases , Far Eastern Memorial Hospital , New Taipei City , Taiwan ;
7g Department of Surgery , Far Eastern Memorial Hospital , New Taipei City , Taiwan ;
8h Department of Internal Medicine , National Taiwan University Hospital , Taipei , Taiwan ;
9i Department of Pediatrics , National Taiwan University Hospital , Taipei , Taiwan.

Abstract

OBJECTIVE:

Several studies suggested that colonic microbiota have impacts on irritable bowel syndrome (IBS) patients. However, the knowledge about the association of small intestine (SI) microbiota with IBS is limited. We aimed to investigate the gut microbiota composition of SI and stool in IBS patients.

MATERIALS AND METHODS:

Biopsies of jejunum mucosa by balloon-assisted enteroscopy and faecal samples from 28 IBS patients and 19 healthy controls were analysed by next-generation sequencing method.

RESULTS:

The three major phyla in SI microbiota of case/control groups were Proteobacteria (32.8/47.7%), Bacteroidetes (25.2/15.3%), and Firmicutes (19.8/11.2%), and those of stool were Bacteroidetes (41.3/45.8%), Firmicutes (40.7/38.2%), and Proteobacteria (15.4/7.1%). Analysis based on the family level, IBS patients had a higher proportion of Veillon